Home › Funds › Thomasville National Bank › GSK
Thomasville National Bank position in GSK
GSK PLC · Health Care
Thomasville National Bank reported holding 871,467 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$45.7M, representing 2.51% of its reported portfolio and ranking #12 among its reported holdings. Thomasville National Bank has disclosed GSK holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Thomasville National Bank's GSK position evolved
Thomasville National Bank first disclosed a stake in GSK in Q3 2023 at 422,046 shares (US$15.3M). The position peaked in Q2 2026 at 871,467 shares, worth US$45.7M. Across 10 filings, Thomasville National Bank increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 871,467 shares valued at US$45.7M — a reduction of -18,631 shares quarter over quarter.. Notable position changes include a 78% increase in Q1 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 422.05K | $15.30M | New |
| Q4 2023 | 430.77K | $15.96M | Add |
| Q1 2024 | 453.80K | $19.45M | Add |
| Q3 2024 | 475.38K | $19.43M | Add |
| Q4 2024 | 491.44K | $16.62M | Add |
| Q1 2025 | 877.00K | $33.97M | Add |
| Q2 2025 | 871.65K | $33.47M | Reduce |
| Q3 2025 | 885.84K | $38.23M | Add |
| Q4 2025 | 890.10K | $43.65M | Hold |
| Q2 2026 | 871.47K | $45.68M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on Thomasville National Bank
FAQ
How long has Thomasville National Bank held GSK?
Thomasville National Bank has disclosed GSK holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is Thomasville National Bank's current position in GSK?
As of Q2 2026, Thomasville National Bank holds 871.47K shares of GSK (GSK PLC), valued at $45.68M, representing 2.51% of its reported portfolio and ranking #12.
Has Thomasville National Bank been buying or selling GSK?
In the latest 13F filing (Q2 2026), Thomasville National Bank reduced its position in GSK. The position peaked in Q2 2026 at 871.47K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.